Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
When it comes to investing in high-yield dividend stocks in the pharmaceutical space, two prominent names often come to mind: (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY).
Both companies have a long history of paying dividends and offer attractive yields, making them popular choices among income-seeking investors. However, when comparing these two stocks, several factors should be considered to determine which one is the better high-yield dividend investment.
Image Source: Getty Images.
Source Fool.com